DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 02/04/2020 declared a dividend of $0.6800 per share

Gilead Sciences Inc (NASDAQ:GILD) on 02/04/2020 declared a dividend of $ 0.6800 per share payable on March 30, 2020 to shareholders of record as of March 13, 2020. Dividend amount recorded is an increase of $ 0.05 from last dividend Paid.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 4.0988545418% and has increased its dividends for 4 successive years.

Gilead Sciences Inc's market cap is $ 83,955,088,560 and has a PE ratio of 31.45. The stock price closed yesterday at $ 66.36 and has a 52 week low/high of $ 60.89 and $ 70.26.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. Co.'s products include Biktarvy for the treatment of HIV-1 infection in certain patients, Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease, Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, and Letairis® (ambrisentan) for the treatment of pulmonary arterial hypertension.

For more information on Gilead Sciences Inc click here.